Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.381 USD | +2.97% | -0.03% | -17.19% |
Financials (USD)
Sales 2024 * | 2.4M | Sales 2025 * | 11M | Capitalization | 28.23M |
---|---|---|---|---|---|
Net income 2024 * | -88M | Net income 2025 * | -86M | EV / Sales 2024 * | 2.4 x |
Net cash position 2024 * | 22.46M | Net cash position 2025 * | 49.7M | EV / Sales 2025 * | -1.95 x |
P/E ratio 2024 * |
-0.32
x | P/E ratio 2025 * |
-0.34
x | Employees | 255 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.55% |
Latest transcript on Singular Genomics Systems, Inc.
1 day | +2.97% | ||
1 week | -0.03% | ||
Current month | -4.99% | ||
1 month | -6.48% | ||
3 months | -30.73% | ||
6 months | -8.41% | ||
Current year | -17.19% |
Managers | Title | Age | Since |
---|---|---|---|
Eli Glezer
FOU | Founder | 55 | 16-05-31 |
Andrew Spaventa
CEO | Chief Executive Officer | 39 | 16-05-31 |
Dalen Meeter
DFI | Director of Finance/CFO | 46 | 19-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Barker
FOU | Founder | 82 | 16-08-31 |
Kim Kamdar
BRD | Director/Board Member | 56 | 17-04-30 |
Michael Pellini
BRD | Director/Board Member | 58 | 17-03-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.00% | 9 M€ | +10.11% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 0.381 | +2.97% | 48,008 |
24-05-23 | 0.37 | -3.97% | 123,233 |
24-05-22 | 0.3853 | -4.56% | 55,940 |
24-05-21 | 0.4037 | +2.72% | 156,102 |
24-05-20 | 0.393 | +3.12% | 155,684 |
Delayed Quote Nasdaq, May 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.19% | 28.23M | |
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+45.66% | 40.65B | |
-10.72% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- OMIC Stock